Correctal Drops 15ml
Item requires a valid prescription
Manufactured By Union Drug
Composition Phenylpropanolamine NA,Dexchlorpheniramine NA
Includes all taxes
Click here to view Alternate brands
Correctal Drops composition:
Interactions / Warnings:
Correctal Drop may cause excessive drowsiness with alcohol
- Do not continue phenylpropanolamine for more than 7 days if your condition does not improve or if you have high fever. \n
- Tell your doctor if you have high blood pressure, heart problems, liver or kidney disease, diabetes, prostate enlargement or visual problems due to increased pressure in the eyes (glaucoma). \n
- Seek immediate medical attention and discontinue medication if you experience difficulty in breathing, sudden swelling or skin reactions, fits, rapid heartbeat or hallucinations. \n
- Use with caution if you are a woman or an elderly patient. Woman may be at a higher risk of haemorrhagic stroke (bleeding in the brain). \n
- Avoid driving or operating machinery if you feel dizzy or drowsy after taking phenylpropanolamine. \n
- Tell your doctor if you are or planning to become pregnant or are breastfeeding. \n
- Do not take if allergic to phenylpropanolamine or any of its ingredients. \n
Correctal Drops Side Effects:
How to use:
Avoid Correctal Drop with caffeine and chocolate as well as food containing caffeine and chocolate such as tea leaves, cocoa beans.
How it works:
Phenylpropanolamine and phenylephrine are different drugs belonging to the same class of medications (nasal decongestants). Both are used to relieve blocked nose or sinuses caused by common cold and seasonal nasal allergies (hay fever)
Q. Does Phenylpropanolamine cause stroke?
Phenylpropanolamine has shown to increase the risk of hemorrhagic stroke (bleeding in the brain). Women are at a higher risk.
Q. Is Phenylpropanolamine a controlled substance?
Phenylpropanolamine is a controlled substance since it can be used for manufacturing of illegal drugs
Q. Is Phenylpropanolamine still on the market?
Phenylpropanolamine is banned in India due to increased risk of haemorrhagic stroke (bleeding in the brain) and is no longer marketed in India
Disclaimer : The content on KauveryMeds.com is only for informational purposes. Always consult a professional medical practitioner regarding any health or medical conditions and their respective diagnosis or treatment. Follow your doctor's advice and do not disregard it because of something you have seen or read on this website